Finzati - Logo
SILO logo

Silo Pharma, Inc.

SILO • Biotechnology
$2.40
▼ -0.05 (-2.04%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.64M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 11.36Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:39 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$2.40
Change-2.04%
Shares Out1.10M
Market Cap$2.64M
Enterprise Value$-640.65K
52W Range2.75 - 15.15
Beta0.80
P/E-0.59
P/S48.75
P/B0.54
P/FCF-0.79
EV/Sales-11.85

Investment DNA

How strong this company looks for long-term investors

37
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 11.36Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 1/8/2021
Industry: Biotechnology
P/B i: 0.54
Debt / Equity i: 0.00
Operating Margin: -5936.95%
Net Margin: -5863.50%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 11.36
Quick Ratio: 11.36
Status: Good

Insider Transactions

Recent executive and insider activity

Weisblum Eric
Transaction: 12/15/2025
BUY
Change
+2,500
Price
$0.41
Filing
12/16/2025
Type
BUY
Weisblum Eric
Transaction: 11/21/2025
BUY
Change
+1,000
Price
$0.36
Filing
11/21/2025
Type
BUY
Weisblum Eric
Transaction: 11/20/2025
BUY
Change
+1,000
Price
$0.37
Filing
11/21/2025
Type
BUY